Susquehanna International Group’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-40,300
Closed -$4.28M 10571
2014
Q2
$4.28M Sell
40,300
-129,500
-76% -$12.7M ﹤0.01% 3336
2014
Q1
$14.8M Buy
169,800
+132,700
+358% +$10.2M 0.01% 1569
2013
Q4
$1.56M Buy
37,100
+1,900
+5% +$78.1K ﹤0.01% 4705
2013
Q3
$1.55M Buy
+35,200
New +$1.46M ﹤0.01% 4544

Susquehanna International Group's FURX Position: Q3 2014 in Review

Susquehanna International Group sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 213,121 shares — an estimated $22.6M sold.

Susquehanna International Group first reported a position in FURX in Q2 2013 and held it in 4 quarters. The position peaked at $22.6M in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Susquehanna International Group reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Susquehanna International Group sold 213,121 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $22.6M.
  • Susquehanna International Group first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 4 quarters.
  • Susquehanna International Group's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $22.6M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Susquehanna International Group's 13F filing for Q3 2014, filed 17 Nov 2014.